Found 22 hits Enz. Inhib. hit(s) with all data for entry = 50015204 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152972
((2S,4R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O3S2/c1-32-10-5-11-33(14-13-32)28(39)25-17-22(38-2)19-35(25)29(37)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,37)/t22-,25+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 430 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152981
((2S,4R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O3S2/c1-41-25-19-28(31(42)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(40)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,40)/t25-,28+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 480 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152972
((2S,4R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O3S2/c1-32-10-5-11-33(14-13-32)28(39)25-17-22(38-2)19-35(25)29(37)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,37)/t22-,25+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 230 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152974
((2S)-N-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12 Show InChI InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 850 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152975
((2S,4R)-4-Methoxy-2-(2-pyridin-2-yl-ethylthiocarba...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O3S2/c1-39-23-17-26(28(40)33-13-10-22-6-2-4-12-32-22)36(19-23)30(38)34-18-21-9-8-20(16-24(21)31)29(37)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,40)(H,34,38)/t23-,26+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152976
((3S,5R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O4S/c1-40-23-17-26(28(37)33-13-10-22-6-2-4-12-32-22)36(19-23)30(39)34-18-21-9-8-20(16-24(21)31)29(38)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,37)(H,34,39)/t23-,26+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152977
((3S,5R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O4S/c1-42-25-19-28(31(40)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(41)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,41)/t25-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152978
((3S,5R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O4S/c1-32-10-5-11-33(14-13-32)28(37)25-17-22(39-2)19-35(25)29(38)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,38)/t22-,25+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152979
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C29H39N5O2S2/c1-21-19-22(27(35)33-14-4-3-8-26-24(33)11-18-38-26)9-10-23(21)20-30-29(36)34-15-5-7-25(34)28(37)32-13-6-12-31(2)16-17-32/h9-11,18-19,25H,3-8,12-17,20H2,1-2H3,(H,30,36)/t25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 890 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152980
((3S,5R)-2-([1,4'']Bipiperidinyl-1''-carbonyl)-4-me...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCCC1 Show InChI InChI=1S/C33H44ClN5O4S/c1-43-26-20-29(32(41)37-16-10-25(11-17-37)36-13-4-2-5-14-36)39(22-26)33(42)35-21-24-9-8-23(19-27(24)34)31(40)38-15-6-3-7-30-28(38)12-18-44-30/h8-9,12,18-19,25-26,29H,2-7,10-11,13-17,20-22H2,1H3,(H,35,42)/t26-,29+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152981
((2S,4R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O3S2/c1-41-25-19-28(31(42)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(40)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,40)/t25-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152974
((2S)-N-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12 Show InChI InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152973
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C28H36ClN5O2S2/c1-31-11-5-12-32(16-15-31)27(37)24-6-4-14-34(24)28(36)30-19-21-9-8-20(18-22(21)29)26(35)33-13-3-2-7-25-23(33)10-17-38-25/h8-10,17-18,24H,2-7,11-16,19H2,1H3,(H,30,36)/t24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152977
((3S,5R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O4S/c1-42-25-19-28(31(40)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(41)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,41)/t25-,28+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152980
((3S,5R)-2-([1,4'']Bipiperidinyl-1''-carbonyl)-4-me...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCCC1 Show InChI InChI=1S/C33H44ClN5O4S/c1-43-26-20-29(32(41)37-16-10-25(11-17-37)36-13-4-2-5-14-36)39(22-26)33(42)35-21-24-9-8-23(19-27(24)34)31(40)38-15-6-3-7-30-28(38)12-18-44-30/h8-9,12,18-19,25-26,29H,2-7,10-11,13-17,20-22H2,1H3,(H,35,42)/t26-,29+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152979
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C29H39N5O2S2/c1-21-19-22(27(35)33-14-4-3-8-26-24(33)11-18-38-26)9-10-23(21)20-30-29(36)34-15-5-7-25(34)28(37)32-13-6-12-31(2)16-17-32/h9-11,18-19,25H,3-8,12-17,20H2,1-2H3,(H,30,36)/t25-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 640 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152982
((2S,4R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCN(C)C Show InChI InChI=1S/C27H36ClN5O4S/c1-31(2)12-10-29-25(34)23-15-20(37-3)17-33(23)27(36)30-16-19-8-7-18(14-21(19)28)26(35)32-11-5-4-6-24-22(32)9-13-38-24/h7-9,13-14,20,23H,4-6,10-12,15-17H2,1-3H3,(H,29,34)(H,30,36)/t20-,23+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152976
((3S,5R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O4S/c1-40-23-17-26(28(37)33-13-10-22-6-2-4-12-32-22)36(19-23)30(39)34-18-21-9-8-20(16-24(21)31)29(38)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,37)(H,34,39)/t23-,26+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 570 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152975
((2S,4R)-4-Methoxy-2-(2-pyridin-2-yl-ethylthiocarba...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O3S2/c1-39-23-17-26(28(40)33-13-10-22-6-2-4-12-32-22)36(19-23)30(38)34-18-21-9-8-20(16-24(21)31)29(37)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,40)(H,34,38)/t23-,26+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152982
((2S,4R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCN(C)C Show InChI InChI=1S/C27H36ClN5O4S/c1-31(2)12-10-29-25(34)23-15-20(37-3)17-33(23)27(36)30-16-19-8-7-18(14-21(19)28)26(35)32-11-5-4-6-24-22(32)9-13-38-24/h7-9,13-14,20,23H,4-6,10-12,15-17H2,1-3H3,(H,29,34)(H,30,36)/t20-,23+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152978
((3S,5R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O4S/c1-32-10-5-11-33(14-13-32)28(37)25-17-22(39-2)19-35(25)29(38)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,38)/t22-,25+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152973
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C28H36ClN5O2S2/c1-31-11-5-12-32(16-15-31)27(37)24-6-4-14-34(24)28(36)30-19-21-9-8-20(18-22(21)29)26(35)33-13-3-2-7-25-23(33)10-17-38-25/h8-10,17-18,24H,2-7,11-16,19H2,1H3,(H,30,36)/t24-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 810 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description
Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107
BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this
Ligand-Target Pair | |
Search and Browse
